Vsig4 - V-set and immunoglobulin domain containing 4 Gene

Species: Rattus norvegicus

Gene Type: protein coding
Gene ID: 312102

Summary

Predicted to enable complement component C3b binding activity. Predicted to be involved in negative regulation of T cell proliferation; negative regulation of complement activation, alternative pathway; and negative regulation of interleukin-2 production. Predicted to be integral component of membrane. Predicted to be part of protein-containing complex. Orthologous to human VSIG4 (V-set and immunoglobulin domain containing 4). [provided by Alliance of Genome Resources, Apr 2022]

Vsig4 Products (1)

mRNA Protein Name
NM_001025004.1 NP_001020175.1 V-set and immunoglobulin domain-containing protein 4 precursor
Protein Preferred Names Protein Names

V-set and immunoglobulin domain-containing protein 4

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P991217 EU-103 Inhibitor 99.0% Phase 1

Pre-clinical Phase

Bioactive Molecules (3)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-RS15709 VSIG4 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS17561 Vsig4 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24019 Vsig4 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
Bioactive MoleculesInhibitory Antibodies (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P991181 VTX-1218 Inhibitor 99.9% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Vsig4 NCBI NCBI:11326